Chembio Diagnostics (CEMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
Cash Flows From Operating Activities | |||||
Net Income | -23,291 | -33,904 | -25,521 | -13,675 | -7,866 |
Depreciation Amortization | 2,553 | 2,931 | 2,697 | 1,916 | 903 |
Income taxes - deferred | N/A | -70 | -396 | -514 | -78 |
Accounts receivable | 4,801 | -8,010 | 284 | 3,764 | -5,150 |
Other Working Capital | 2,038 | -12,157 | -704 | 1,541 | -5,373 |
Other Operating Activity | 1,205 | 20,324 | 4,753 | -2,088 | 5,783 |
Operating Cash Flow | $-12,694 | $-30,886 | $-18,887 | $-9,056 | $-11,781 |
Cash Flows From Investing Activities | |||||
PPE Investments | -1,451 | -1,824 | -3,961 | -3,503 | -1,467 |
Net Acquisitions | N/A | N/A | N/A | -100 | -5,491 |
Purchase Sale Intangibles | N/A | -33 | -206 | -297 | 0 |
Other Investing Activity | 0 | -33 | -206 | -151 | 0 |
Investing Cash Flow | $-1,451 | $-1,858 | $-4,167 | $-3,754 | $-6,958 |
Cash Flows From Financing Activities | |||||
Debt Issued | N/A | N/A | 2,978 | 18,850 | N/A |
Debt Repayment | -971 | -62 | -3,210 | -202 | -65 |
Common Stock Issued | 4,312 | 38,898 | 28,437 | 33 | 27,548 |
Other Financing Activity | 26 | -145 | -442 | -186 | 0 |
Financing Cash Flow | $3,367 | $38,690 | $27,764 | $18,495 | $27,484 |
Exchange Rate Effect | 184 | -240 | 85 | 62 | -10 |
Beginning Cash Position | 28,773 | 23,066 | 18,271 | 12,525 | 3,790 |
End Cash Position | 18,179 | 28,773 | 23,066 | 18,271 | 12,525 |
Net Cash Flow | $-10,594 | $5,707 | $4,795 | $5,747 | $8,734 |
Free Cash Flow | |||||
Operating Cash Flow | -12,694 | -30,886 | -18,887 | -9,056 | -11,781 |
Capital Expenditure | -1,451 | -1,824 | -3,961 | -3,503 | -1,467 |
Free Cash Flow | -14,145 | -32,710 | -22,849 | -12,558 | -13,249 |